SkyePharma wins Japanese approval for inhaled Flutiform; SafeShot gathers $9M for injectables biz;

> The Japanese Ministry of Health approved SkyePharma's inhaled asthma treatment Flutiform, giving the company "several million" in milestone payments from its Japanese partner, Kyorin Pharmaceutical. Item

> SafeShot Technologies secured $9 million in financing--$6 million now on top of $3 million from 2012--which it will use to bolster its sterile injectable business. Release

> Researchers at the University of Twente in the Netherlands have developed multifunctional nanocontainers for imaging, targeting and drug release. Story

> Oramed ($ORMP) will participate in Barclays' Israel Biotech Corporate Day in Zurich, Switzerland, this month. Release

Suggested Articles

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.

Bexson Biomedical and Stevanato Group teamed up to develop a ketamine pump that may help patients better manage pain at home.

Australia's University of New South Wales and Uka Tarsadia University in India will join forces to explore contact lenses for ocular drug delivery.